Original Article
Ocular Manifestations in HIV/AIDS Patients Undergoing Highly Active
Antiretroviral Therapy
Muhammad Abdul Rehman Akram, Mazen Ahmed Alzahrani,
Asim Mahmood, Thamer Basodan, Eman Oudah Alghamdi, Ali Alansari
Pak J Ophthalmol 2019, Vol. 35, No.
3
. . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . .. . .. . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . .
See end of article for authors affiliations …..……………………….. Correspondence to: Muhammad Abdul Rehman Ophthalmology Clinic
of East Jeddah Hospital, Western Region, Saudi Arabia Email: abdulrehmandoctor@yahoo.com |
Purpose: To study Human Immunodeficiency Virus (HIV) / Acquired
Immunodeficiency Syndrome (AIDS) related ocular manifestations in patients
undergoing highly active anti-retroviral therapy (HAART) in Jeddah, Saudi
Arabia. Study Design: Descriptive study. Place and Duration of Study: Ophthalmology Clinic of East Jeddah Hospital. Kingdom of Saudi Arabia, during 2016-2017. Material and Methods: All patients who were
positive for HIV/AIDS and taking highly active anti-retroviral therapy seen
in the department of Infectious diseases of our hospital were included in the
study. The data for the 47 HIV/AIDS positive referrals was collected from the
Infectious Diseases Department by taking history, clinical examinations, and
laboratory investigations. The ophthalmological examination consisted of
adnexal examination, best corrected visual acuity, Intraocular pressure
(IOP), anterior and posterior segment examination, B-scan and MRI. Results: There were 47 patients included in the study.
There was one patient each of retinal necrosis, anterior uveitis “and”
neovascular glaucoma, pterygium, sixth nerve palsy, bacterial conjunctivitis
and adenoviral conjunctivitis. Two cases presented with HIV microangiopathy,
blepharitis, cortical blindness after brain abscess, herpes infection, Kaposi
sarcoma and cytomegalovirus (CMV) retinitis. Three patients presented with
meningitis and six with dry eyes. Eight patients presented with cataracts and
ten with refractive errors tuberculosis. Conclusion: Ocular
manifestations of HIV infection are relatively infrequent in patients on HAART as this has reduced the HIV-related
complications in ophthalmology. Keywords: Human Immunodeficiency Virus, Acquired
Immunodeficiency Syndrome, Highly Active Anti-Retroviral Therapy. |
AIDS is caused by HIV and may affect any part of the body1.
Nearly 36.7 million people are living with HIV/AIDS, and the mortality rate
worldwide was 1.1 million reported cases up to 20152. Kingdom of
Saudi Arabia is one of the least affected states in the world HIV map3,4.
Since HIV leads to disruption of the immune
system, all body parts are susceptible to infection, including eye. Healthy HIV
patients are not liable to encounter eye issues identified with a decreased
immune system. However, 70 percent of patients with AIDS experience ocular
diseases5.
Eye complications, as a result of suppressed
immune system consist of HIV retinopathy, tiny hemorrhages and cotton wool spots in the retina. One of the severe eye problems associated with
AIDS is cytomegalovirus (CMV) retinitis, which is seen in some individuals who
have further developed stages of AIDS where CD4 lymphocyte count is < 50 cells/µL. It shows consistent
inflammation of the retina, often leading to retinal deterioration and visual
loss within few months.
CMV retinitis can lead to a
detached retina, causing severe vision loss unless treated surgically6.
Kaposi's sarcoma is an uncommon type of malignancy that happens in patients
with AIDS. This growth can cause violet sores to form on eyelids, and purple,
plump lesions to develop on the conjunctiva. Kaposi’s sarcoma may appear unexpectedly,
although it mainly does not hurt the eye, and can be easily treated7.
Research has demonstrated that increased number of cases presenting with
conjunctival squamous cell carcinoma is related to exposure to daylight
combined with infection with the human papilloma virus infection (HPV)
sometimes identified with HIV disease8. The occurrence of eye
diseases, related with a sexually transmitted disease, might be more typical in
patients with HIV, such as herpes infection, toxoplasmosis, gonorrhoea,
chlamydia, candida, microsporidia and pneumocystis5.
The objective of this study is to determine HIV/Acquired
Immunodeficiency Syndrome (AIDS) related ocular manifestations during a one year
study conducted at East Jeddah Hospital, Jeddah, Saudi Arabia.
MATERIAL AND METHODS
A one year retrospective study was conducted in
the clinic of East Jeddah Hospital, in the western region of Kingdom of Saudi
Arabia during 2016-2017. All patients who were positive for HIV/AIDS and taking
highly active anti-retroviral therapy seen in the Infectious disease of our
hospital were included in the study. All patients with other infectious
diseases were excluded from the study. The data for the 47 HIV/AIDS positive
referrals was collected from the Infectious Diseases Department by taking
history, clinical examinations and laboratory investigations. The ophthalmological examination
consisted of adnexal examination, best corrected visual acuity, Intraocular
pressure (IOP), anterior and posterior segment examination, B scan and MRI.
RESULTS
There were 47 patients diagnosed and treated with an
eye-related problem due to AIDS. There were single cases of retinal necrosis,
anterior uveitis, neovascular glaucoma, pterygium, sixth nerve palsy, bacterial
conjunctivitis and adenoviral conjunctivitis each. Two cases presented with HIV
microangiopathy, blepharitis, cortical blindness after brain abscess, herpes
infection, Kaposi sarcoma, cytomegalovirus (CMV) retinitis and two patients
presented with Molluscum contagiosum. Three patients presented with tuberculous
meningitis, and six with dry eyes. Eight patients presented with cataracts, and
ten with refractive errors (Figure 1).
Fig. 1: Pie chart
of the ocular manifestations of HIV/AIDS at East Jeddah Hospital, Jeddah, KSA.
The descriptive statistics of observed patients is shown in
Table 1. Ocular manifestations also occur in patients with different viral load
levels. All severe blinding complications we encountered, presented in newly-diagnosed
patients with high viral loads and a CD4 count less than 100. The balance of
male/female patients in our study is shown in Fig 2. The frequency of males
living with HIV/AIDS is almost threefold the number of female patients. Out of
10 patients, seven were male.
Table 1:
Descriptive Statistics of observed
patients.
|
N |
Minimum |
Maximum |
Mean |
Std.
Deviation |
Variance |
|
Statistic |
Statistic |
Statistic |
Statistic |
Std.
Error |
Statistic |
Statistic |
|
Age |
47 |
9 |
74 |
49.85 |
2.197 |
15.064 |
226.912 |
CD4 |
47 |
18 |
1392 |
530.11 |
47.345 |
324.582 |
105353.445 |
Valid N (list wise) |
47 |
|
|
|
|
|
|
Fig. 2: HIV/AIDS
patients presented in eye unit East Jeddah Hospital.
Fig. 3: The correlation coefficient of CD4 ratio with the
complication and HIV manifestations.
The correlation coefficient of CD4 ratio with the
complication and HIV manifestations is shown in Fig. 3, which shows a strong
positive correlation between CD4 and HIV manifestation.
DISCUSSION
In 2007, there were almost 33 million people diagnosed with
HIV throughout the world. Out of which 95% deaths occurred in the developing
countries9. It is usually transmitted via sexual contact, contact
with infected blood or blood products (specifically by sharing of needles) and
from the infected mother to child in utero. Diagnosis is by detection of
virus-specific antibodies confirmed by a blood test and monitoring by PCR.
To date, Kingdom of Saudi Arabia is a low
HIV-prevalence nation. There is an active testing program in place for
non-Saudis, who apply for or renew work contracts (34%), for new residents (23%)
and prisoners (15%). A significant portion of non-Saudi HIV cases, as a rule,
have ready access to testing4. Kingdom of Saudi Arabia has kept up a
coordinated effort to keep up-to-date with the National AIDS Program (NAP), UN
agencies, and local civil society organizations (CSO)9.
In this
study, we tried to find out eye manifestations of HIV/AIDS in patients ranging from 9-74 years with a mean of 49.85 years. Out of
these 76.6% of them were male. The presenting cases were split: 21% with
reflective errors, 17% with cataracts, 13% with dry eyes, 6% with TB meningitis
and, 4% with CMV retinitis, Kaposi sarcoma, herpes infection, cortical
blindness, blepharitis and HIV microangiopathy. Whereas a diagnosis of
adenoviral conjunctivitis, bacterial conjunctivitis, sixth nerve palsy,
pterygium, anterior uveitis and retinal necrosis presented in 2% of the total
patients. This result could be explained by the fact that in Saudi Arabia male
adult patients are more affected by HIV Ocular manifestations dependent
upon CD4+ T-lymphocyte counts. Generally,
Kaposi sarcoma, herpes zoster ophthalmicus, candidiasis, and lymphoma have been
commonly seen in earlier stages.
Comparative
to other studies, tuberculosis, toxoplasmosis and pneumocystis were observed in
advanced cases. Cytomegalovirus retinitis and
mycobacterium-avium complex infection were noted in patients with severely
reduced CD4 counts6. Majority of cases seen in the current study (mean
CD4 530.11) presented with significant dry eyes. In six patients (13% of the
sample) Dry Eye Syndrome was present. The causes of dry eye can vary from
blepharitis to lacrimal glands disturbance. According to Acharya et al5-20,
occurrence of lid infections is higher in these patients. Lid lubrication was
maintained for longer than usual periods and omega 3 was recommended to be
taken in multivitamin form and from natural plant sources.
The second leading ocular manifestation related
to patients living with HIV/AIDS in our study was occurrence of cataracts, 17%
presented earlier than non-HIV/AIDS-affected populations-7. Herpes
zoster ophthalmicus is documented as occurring in early and advanced stages of
HIV/AIDS and at 4.3% among our study. We noted 2.0% of patients with outer
retinal necrosis, characterized by fulminant vitreous inflammation, often
leading to blindness of both eyes consecutively. There have been several
studies, in Africa illustrating high prevalence in groups similar to our study
cohort9-10 reflecting the efficiency of maintaining HAART therapy
with reduced ocular complications related to HIV/AIDS18—17-19.
Kaposi sarcoma (KS) is a multifocal vascular tumor, the most common cancer
related to HIV 11-14 and is related to the herpes virus 8 (HHV-8) infection.
Kaposi's sarcoma may cause lesions in multiple sites such as lymph nodes, skin,
liver, spleen, lungs, and digestive tract12,15,16. Although Kaposi
sarcoma can occur at any time, it tends to manifest at CD4 count < 350
cells/mm3 13-21.
CONCLUSION
In our one year study, 47 patients were observed with
dominant incidences of dry eyes, cataracts, and refraction. HAART treatment is
responsible for decreasing the HIV related complications in ophthalmology. The treatment with HAART is highly effective in controlling disease,
but it is not enough for the prevention of some ocular complications, some of
which may lead to irreversible blindness, if untreated. Therefore, we strongly recommend obtaining a strategy for
visiting an ophthalmologist early on after
diagnosis.
We strongly recommend
that if a patient is living with a diagnosis of HIV/AIDS, they should see their
ophthalmologist immediately if they experience blurred vision, floating spots
or "spider-webs," flashlights or blind spots.
ACKNOWLEDGEMENTS
The authors gratefully
acknowledge East Jeddah Hospital for
providing support for this study.
REFERENCES
1.
Academy of Ophthalmology, 2017. How Does HIV/
AIDS Affect the Eye. American [cited 28 July 2017].
http://www.aao.org/eye-health/diseases/how-does-hiv-aids-affect-eye.
2. WHO 2016. Global Health
Sector Strategy on HIV/AIDS 2016.URL:http://http://www.who.int/gho/hiv/en/.
3. Mazroa MA, Kabbash IA, Felemban SM, Stephens GM, Al-Hakeem
RF, Zumla AI et al. HIV case notification rates in the Kingdom of Saudi Arabia
over the past decade (2000-2009). PLoS
One. 2012;7(9):e45919.
doi: 10.1371/journal.pone.0045919. Epub 2012 Sep 26. PMID: 23049892; PMCID:
PMC3458799.
4. Global AIDS Response
Progress Report, 2017. Kingdom of Saudi Arabia: Ministry of Health; [cited20
July 2017].
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0045919
5. Kim YS, Sun HJ, Kim TH, Kang KD, Lee SJ. Ocular Manifestations
of Acquired Immunodeficiency Syndrome. Korean J Ophthalmol. 2015;29(4):241-8.
doi: 10.3341/kjo.2015.29.4.241.
6. Arantes TE, Faria E, Garcia CR, Saraceno JJF,
Muccioli C. Clinical features and outcomes of AIDS-related cytomegalovirus
retinitis in the era of highly active antiretroviral therapy. Arq Bras
Oftalmol. 2010; 73 (1): 16-21. Doi: http://dx.doi.org/10.1590/S0004-27492010000100003.
7. Kempen JH, Sugar EA, Varma
R, Dunn JP, Heinemann MH, Jabs DA et al. Risk of Cataract among subjects
with acquired immune deficiency syndrome free of ocular opportunistic
infections. Studies of Ocular Complications of AIDS Research Group. Opthamology
2014; 121 (12): 2317-24.
8. Rathi
SG, Ganguly Kapoor A, Kaliki S. Ocular surface squamous neoplasia in
HIV-infected patients: current perspectives. HIV AIDS (Auckl). 2018 Mar
14; 10: 33-45. Doi: 10.2147/HIV.S120517. PMID: 29559813; PMCID: PMC5857154
9. UNAIDS (Joint United Nations
Global AIDS Programme). Global report: UNAIDS report on the global AIDS
epidemic 2013. Accessed at
www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/unaids_global_report_2013_en.pdf
on July 23, 2014.
10. Margolis
TP, Milner MS, Shama A, Hodge W, Seiff S. Herpes zoster ophthalmicus in
patients with human immunodeficiency virus infection. Am Ophthalmol, 1998; 125
(3): 285–291.
11. Rubinstein PG, Aboulafia DM, Zloza A. Malignancies in
HIV/AIDS: from epidemiology to therapeutic challenges. AIDS. 2014 Feb 20; 28 (4): 453-65.
Doi: 10.1097/QAD.0000000000000071.
12. Rasmussen LD, Kessel L,
Molander LD, Pedersen C, Gerstoft J, Kronborg G et al. Risk
of Cataract Surgery in HIV-Infected Individuals: A Danish nationwide
population-based cohort study. Clin
Infect Dis. 2011; 53 (11): 1156-1163. Doi: 10.1093/cid/cir675
13. Vaishnani
JB, Bosamiya SS, Momin AM. Kaposi’s sarcoma: A presenting sign of HIV. Indian
J Dermatol Venerol Leprol. 2010 Mar-Apr; 76 (2): 215–8.
14. Cheung
MC, Pantanowitz L, Dezube BJ. AIDS-related malignancies: Emerging
challenges in the era of highly active antiretroviral therapy. Oncologist.
2005; 10: 412-426.
15. Franceschi S, Lise M,
Clifford GM, Rickenbach M, Levi F, Maspoli M et al. Swiss HIV Cohort Study.
Changing patterns of cancer incidence in the early- and late-HAART periods: The
Swiss HIV Cohort Study. Br J Cancer, 2010; 103: 416-422.
16. Gopal
S, Achenbach CJ, Yanik EL, et al. Moving forward in HIV-associated cancer.
J Clin Oncol. 2014; 32: 876-880.
17. Guiguet M, Boué F, Cadranel J, Lang JM, Rosenthal
E, Costagliola D et al. Clinical Epidemiology Group of the FHDH-ANRS CO4 cohort. Effect of
immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of
individual malignancies (FHDH-ANRS CO4): A prospective cohort study. Lancet
Oncol. 2009; 10: 1152-1159.
18. Thompson MA, Aberg JA, Cahn P, Montaner JS,
Rizzardini G, Telenti A et al. Antiretroviral treatment of adult HIV infection:
2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010; 304:
321-333.
19. Rutayisire DL, Saiba SE. Ocular manifestations related to HIV/AIDS at Kigali University
Teaching Hospital. Rwanda, Rawanda Med J. 2010; 68 (4):47-51.
20. Balne PK, Agrawal R,
Au VB, Lee B, Loo E, Tong L et al. Dataset of longitudinal analysis of tear cytokine levels,
CD4, CD8 counts and HIV viral load in dry eye patients with HIV infection. Data Brief. 2017; 3 (11): 152-154.
Doi: 10.1016/j.dib.2017.01.014.
21. Nancy FC. Is
Kaposi’s Sarcoma Occurring at Higher CD4 Counts Over the Course of the HIV
Epidemic? 2011 URL:https://www.ncbi.nlm.nih.gov/pmc
/articles/ PMC2978255/
Author’s Affiliation
Dr. Muhammad Abdul Rehman Akram
Ophthalmology Clinic of East Jeddah Hospital,
Western Region, Saudi Arabia
Dr. Mazen Ahmed Alzahrani
Ophthalmology Clinic of East Jeddah Hospital,
Western Region, Saudi Arabia
Dr. Asim Mahmood
Multan Medical and Dental College,
Multan Pakistan
Dr. Thamer Basodan
Ophthalmology Clinic of East Jeddah Hospital, Western
Region, Saudi Arabia
Eman Oudah Alghamdi
Ophthalmology Clinic of East Jeddah Hospital,
Western Region, Saudi Arabia
Dr. Ali Alansari
Infectious disease Clinic of East Jeddah
Hospital, Western Region, Saudi Arabia
Author’s Contribution
Muhammad Abdul Rehman
Study Design, Data Collection,
Manuscript writing and Critical Analysis.
Dr. Mazen Ahmed Alzahrani
Co Author participated in
discussion and collected the data.
Dr. Asim Mahmood
Review analysis
Dr. Thamer Basodan
Data collection.
Eman Oudah Alghamdi
Done Optometry examination of the
patients
Dr. Ali Alansari
Infectious disease clinic,
Maintaining HAART therapy.